A new technical paper titled “Hybrid tungsten oxyselenide/graphene electrodes for near-lossless 2D semiconductor phase ...
Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...
Environmentally friendly buildings are highly attractive for sustainable development and efficient energy consumption. Recently, scientists have made significant strides towards the development of ...
We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug ...
Power management is one of the keys for developing successful semiconductors products. There are virtually no applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results